Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
Prometheus Biosciences To Be Acquired By Merck
(RTTNews) – In a bid to strengthen its immunology pipeline, Merck (MRK) has agreed to acquire Prometheus Biosciences Inc. (RXDX) for $200.00 per share in
Merck in Late-Stage Talks to Acquire Prometheus Biosciences
Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the